reuters.com
FDA advisers back first four of seven unapproved peptides under review for looser rules
A majority of the U.S. FDA's outside advisers on Thursday supported allowing pharmacies to compound the first four of seven peptides under review, advancing efforts championed by Health Secretary Rob...
